LRMR
Larimar Therapeutics Inc. Common Stock
$2.910+-0.000 (-0.000%)
Real-time Price
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.910
High
$2.910
Low
$2.910
Volume
0.37M
Company Fundamentals
Trading Stats
Related News
GlobeNewswire
Larimar Therapeutics Reports First Quarter 2025 Financial Results
FDA stated as part of a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval BLA seeking accelerated approval
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.